Brief: Bioxyne Says March Revenues 147% Up Quarter On Quarter
28/04/2022 02:42
April 28 (Reuters) - Bioxyne:
* MARCH REVENUES 147% UP QUARTER ON QUARTER
Source text for Eikon: ID:nASX4nmjvJ
Further company coverage: BXN.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BLS Pharmaceuticals
See all newsBrief: BLS Pharmaceuticals Posts Q1 FY27 Revenue A$26.7M
Brief: BLS Pharmaceuticals Reports Record Q1 FY27 Revenue Of A$26.7 Million
Australia's BLS Pharmaceuticals extends gains on upbeat outlook, strong results
Brief: BLS Pharmaceuticals Sees FY27 Adjusted. EBITDA Margin 23% - 26%
Brief: BLS Pharmaceuticals Posts FY Net Profit After Tax Of A$15.4 MLN